Description
Generic Version of Dapagliflozin/Saxagliptin Available in India?
Dapagliflozin/Saxagliptin is the generic name of the medication and is its international nonproprietary name. Dapagliflozin/Saxagliptin is marketed under the brand name Qtern among others.
Dapagliflozin/saxagliptin, is a fixed-dose combination anti-diabetic medication used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a combination of dapagliflozin and saxagliptin.
The most common side effects include upper respiratory tract infection (such as nose and throat infections) and, when used with a sulphonylurea, hypoglycaemia (low blood glucose levels).
Dapagliflozin/saxagliptin was approved for medical use in the European Union in July 2016, and in the United States in February 2017
Will this product be accessible across all regions of India?
The product – Qtern (Dapagliflozin + Saxagliptin) Tablet will be available across India on request. Dapagliflozin/Saxagliptin is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.